Bull & Bear

Figures converted from JPY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Watchlist — the moat is real but the entry is poor, and one observable data point in three months sets the trajectory of the entire debate. Bull's sum-of-the-parts arithmetic is honest ($1.11B market cap vs ~$1.39B carved value) and the counter-cyclical evidence is the cleanest in listed wafers. Bear's case is equally honest: management itself authored a four-year margin walk-down to 16.5% by FY2028, the reclaim segment margin has slipped 370 bps over three years, and the prior mid-term plan was quietly retired. The whole debate collapses onto one shared fact — reclaim segment operating margin — and the first decisive read prints in August 2026. Paying $42 (RSI 87, +150% TTM, 49% above last published consensus) to sit through that read is poor risk control; the better course is to wait for the Q2 FY2026 segment table.

Bull Case

No Results

Bull's price target is $60 / share (~$1.58B market cap) over a 12–18 month window, built on a sum-of-the-parts on FY2027E earnings power: reclaim $72M EBIT × 13x, prime $28M × 6x, equipment $11M × 5x, less HQ overhead, plus $473M residual net cash. Cross-checks to ~11x FY27E EV/EBITDA, still inside the peer range. The disconfirming signal Bull names is reclaim segment operating margin below 33% for two consecutive quarters — the same metric the bear is tracking, just at a lower threshold.

Bear Case

No Results

Bear's downside target is $26 / share (-37% from $42) over 12–18 months, built from 6.0x EV/EBITDA on FY26E normalized EBITDA of ~$113M (stripping the $13M Gritek subsidy and the FY24-25 negative-goodwill flatter) plus $189M residual net cash after the FY26-28 capex draw, with a further 20% China-policy / governance / illiquidity discount on top. The cover signal is reclaim segment operating margin at 37%+ for two consecutive quarters while Sanbongi Plant 7 commissions on schedule above 85% utilization — i.e., evidence the FY25 slip was mix-and-ramp, not structural.

The Real Debate

No Results

Verdict

Watchlist. The two sides hold roughly equal weight on the durable question, with a tilt toward Bear at the current price. Bull's SOTP arithmetic is real and the counter-cyclical evidence is the cleanest in listed wafers, but the ~25% gap to fair value is too narrow to absorb a parabolic chart (+150% TTM, weekly RSI 87, 49% above the last published consensus mark) and management's own four-year margin walk-down. The single most important tension is the reclaim segment margin trajectory — the metric is already 370 bps off the FY22 peak, sits roughly 200 bps above the published moat-breaker, and the first decisive read prints in three months. Bull's read may hold because the FY25 slip is plausibly mix-and-ramp from RSPDH consolidation and Sanbongi commissioning; in that case a 37%+ Q1 FY26 print supports re-segmenting the model. The condition that shifts this to Lean Long is two consecutive reclaim segment margin prints at 37% or higher with Sanbongi Plant 7 commissioning above 85% utilization (durable thesis confirmation); a single Q1 FY26 print at 37%+ is a near-term evidence marker, not a thesis-breaker. The condition that shifts this to Lean Short / Avoid is two consecutive reclaim prints below 35%, which is the moat-breaker management itself effectively endorsed by guiding overall margin down to 16.5%.